Support services that make a meaningful difference to people with hemophilia B

$0 for 95% of patients

Over 95% of commercially insured patients paid $0 for IDELVION through the co-pay program in 2020.1

IDELVION free trial for patients

A free trial of IDELVION

So your patients can see if it is right for them.*


Co-pay savings for IDELVION

Co-pay savings

Eligible patients can pay $0 co-pay up to the program maximum towards out-of-pocket costs associated with IDELVION therapy.

Co-pay savings for IDELVION

CSL Behring AssuranceSM

To help people continue to receive IDELVION if they have a lapse in insurance coverage.

IDELVION Advocate Program

IDELVION Advocate Program

Patients can have one-on-one conversations with advocates about hemophilia B, product experience, and other topics.

IDELVION reimbursement and access support

Reimbursement and access support

Find information, including coding and reimbursement guidance.

IDELVION Patient Assistance Program

Patient Assistance Program

For patients without insurance or who can’t afford treatment.

*Because dosing is based on various patient traits (eg, weight, Factor IX levels), there may be a cap to the trial. Terms and conditions apply.

†Subject to terms and conditions of the co-pay assistance program. To read the full terms and conditions, visit CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.

‡Terms, conditions, and limitations apply. Visit here to view terms and conditions.

Reference: 1. Data on file Available from CSL Behring as DOF IDL-009.

You are now leaving the current website.

Do you want to continue?